Literature DB >> 17950914

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.

James L M Ferrara1, Claudio Anasetti, Edward Stadtmauer, Joseph Antin, John Wingard, Stephanie Lee, John Levine, Kirk Schultz, Frederick Appelbaum, Robert Negrin, Sergio Giralt, Christopher Bredeson, Helen Heslop, Mary Horowitz.   

Abstract

Outcomes of hematopoietic cell transplantation are steadily improving. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. In June 2007 the Blood and Marrow Transplant Clinical Trials Network convened a State of the Science Symposium of more than 200 participants in Ann Arbor to identify the most compelling clinical research opportunities in the field. This report summarizes the symposium's discussions and identifies eleven high priority clinical trials that the network plans to pursue over the course of the next several years.

Entities:  

Mesh:

Year:  2007        PMID: 17950914     DOI: 10.1016/j.bbmt.2007.08.005

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  14 in total

1.  Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials.

Authors:  Linda M Griffith; Steven Z Pavletic; Stephanie J Lee; Paul J Martin; Kirk R Schultz; Georgia B Vogelsang
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

2.  CARs on track in the clinic.

Authors:  Donald B Kohn; Gianpietro Dotti; Renier Brentjens; Barbara Savoldo; Michael Jensen; Laurence Jn Cooper; Carl H June; Steven Rosenberg; Michel Sadelain; Helen E Heslop
Journal:  Mol Ther       Date:  2011-03       Impact factor: 11.454

Review 3.  The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell Transplantation.

Authors: 
Journal:  Biol Blood Marrow Transplant       Date:  2016-07-11       Impact factor: 5.742

4.  Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network.

Authors:  John E Levine; Joseph H Antin; Carl E Allen; Lauri M Burroughs; Kenneth R Cooke; Steven Devine; Helen Heslop; Ryotaro Nakamura; Julie An Talano; Gregory Yanik; Nancy DiFronzo
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-05       Impact factor: 5.742

5.  Blood and marrow transplant clinical trials network state of the Science Symposium 2014.

Authors:  Frederick R Appelbaum; Claudio Anasetti; Joseph H Antin; Harold Atkins; Stella Davies; Steven Devine; Sergio Giralt; Helen Heslop; Ginna Laport; Stephanie J Lee; Brent Logan; Marcelo Pasquini; Michael Pulsipher; Edward Stadtmauer; John R Wingard; Mary M Horowitz
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-15       Impact factor: 5.742

6.  Correlation and Agreement of Handheld Spirometry with Laboratory Spirometry in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:  Guang-Shing Cheng; Angela P Campbell; Hu Xie; Zach Stednick; Cheryl Callais; Wendy M Leisenring; Janet A Englund; Jason W Chien; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-31       Impact factor: 5.742

7.  Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.

Authors:  Sergio Giralt; Luciano J Costa; David Maloney; Amrita Krishnan; Mingwei Fei; Joseph H Antin; Claudio Brunstein; Nancy Geller; Stacey Goodman; Parameswaran Hari; Brent Logan; Robert Lowsky; Muzaffar H Qazilbash; Firoozeh Sahebi; George Somlo; Scott Rowley; Dan T Vogl; David H Vesole; Marcelo Pasquini; Edward Stadtmauer
Journal:  Biol Blood Marrow Transplant       Date:  2019-11-19       Impact factor: 5.742

8.  Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation.

Authors:  Florian Keusch; Rohini Rao; Lawrence Chang; James Lepkowski; Pavan Reddy; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-24       Impact factor: 5.742

Review 9.  Quality of life after allogeneic hematopoietic cell transplantation.

Authors:  Joseph Pidala; Claudio Anasetti; Heather Jim
Journal:  Blood       Date:  2009-03-31       Impact factor: 22.113

Review 10.  Building a Fit for Purpose Clinical Trials Infrastructure to Accelerate the Assessment of Novel Hematopoietic Cell Transplantation Strategies and Cellular Immunotherapies.

Authors:  Steven M Devine; Mary M Horowitz
Journal:  J Clin Oncol       Date:  2021-01-12       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.